Bachem Holding AG
ISIN CH1176493729
|WKN A3DLKE
Market cap (in EUR)
4,024.10 m
Country
Switzerland
Sector
Healthcare
Dividend yield
1.60%
Overview
Description
Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.
Healthcare Healthcare Services Outsourced Development and Manufacturing Services Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 4,024.10 m |
| EPS, EUR | - |
| P/B ratio | 2.70 |
| P/E ratio | 31.21 |
| Dividend yield | 1.60% |
Income statement (2024)
| Revenue, EUR | 635.84 m |
| Net income, EUR | 126.32 m |
| Profit margin | 19.87% |
What ETF is Bachem Holding AG in?
There are 138 ETFs which contain Bachem Holding AG. All of these ETFs are listed in the table below. The ETF with the largest weighting of Bachem Holding AG is the BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
